%0 Journal Article
%T Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer
%A Alice Dragomir
%A Girish S. Kulkarni
%A Kathy Li
%A Peter C. Black
%A Wassim Kassouf
%A Zachary Klaassen
%J Archive of "Canadian Urological Association Journal".
%D 2017
%R 10.5489/cuaj.4568
%X Previous studies have suggested cost-savings using blue light cystoscopy (BLC) with hexaminolevulinate (HAL) compared to white light cystoscopy (WLC) during transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), secondary to improvements in recurrence and progression rates; however, these studies have used ¡®best case scenario¡¯ recurrence rate probabilities, thus decreasing generalizability of the findings. The objective of this study was to perform a contemporary cost-effectiveness assessment of BLC compared to WLC at the time of TURBT
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472462/